The AEROBIKA® OPEP Device from Monaghan Medical
The AEROBIKA® Oscillating Positive Expiratory Pressure Device, or OPEP device, helps to open and clear the airways of your lungs. You may need assistance with this if you have a lung condition like COPD, Bronchiectasis or Cystic Fibrosis.
How can the AEROBIKA® OPEP device help?
Cough and shortness of breath may be caused by mucus that gets trapped in the lungs. The AEROBIKA® OPEP Device can help remove this mucus and has been clinically proven to improve ventilation, lung function and quality of life as well as reduce COPD flare ups.1
- Reduces COPD readmissions by 28% in the critical 30-day period
- Trend toward shorter length of stay
- Reduced use of oral corticosteroids and antibiotic treatments
- Improves lung function and ventilation in COPD
- Reduces post-operative readmissions by 39% in the critical 30-day period
- Use of the device resulted in shorter length of stay and significantly lower costs
- Cost effective addition to standard of care




Hospital Cost Savings Estimate
In peer-reviewed published studies, the AEROBIKA® Oscillating Positive Expiratory Pressure (OPEP) device has been shown to support cost savings in both COPD Exacerbation and Post-Operative Recovery in a hospital setting. Use the calculator to the right to estimate the cost savings your facility could achieve by implementing the AEROBIKA® OPEP device to your existing standard of care.
How It Works

- Before Use: Airways inflamed, collapsed, and plugged with mucus.
- As you exhale through the device, positive pressure will hold the airways open. Think of how you feel when you blow up a balloon. It is the positive pressure that holds the balloon open. Inside your lungs, the positive pressure opens up small airways that may be blocked by mucus.
- As the airways open, the device switches quickly between higher and lower resistance. This may feel like vibrations or pulses which act to loosen the mucus from the walls of your lungs. The frequency of the oscillations closely match the ones within your lungs, helping move mucus to the larger airways. This makes it easier for you to cough up the secretions.
- With the airways opened and the mucus moved out of the airways, your inhaled medication may work better.2
How To Use

- CLOSE LIPS around mouthpiece
- INHALE and HOLD for 2-3 seconds
- EXHALE – slowly but firmly
- REPEAT as directed
These are shortened user instructions. Always review the complete instructions that came with your device.
Frequently Asked Questions
HOW OFTEN SHOULD THE DEVICE BE USED?
Frequency of use will be determined by the patients’ disease state, their ability and the goal for using the device. There is no one-size fits all answer. Ideally, patients will work up to being able to use the device twice each day for 10-20 minutes each time. Clinical judgement should be used in determining what is right for each patient.
WHAT ARE THE APPROVED METHODS FOR CLEANING AND HIGH-LEVEL DISINFECTION?
The approved cleaning methods are: soap and water or top rack dishwasher
The approved disinfection methods are: boiling for 5 minutes, 70% isopropyl alcohol soak for 5 minutes, 3% Hydrogen Peroxide soak for 30 minutes, or microwave steam bag (according to manufacturer’s instructions).
CAN THE AEROBIKA® OPEP DEVICE BE USED WITH A MASK?
We do not recommend use with a mask. In order to maintain a good seal, an unvented mask would need to be used. These types of masks have soft, flexible edges to make it easier to prevent leaks. However, the same properties that make them ideal to create a seal may also impact the effectiveness of the treatment you are giving. The patient would still need to hold the mask and device for the duration of treatment, so we recommend use with a mouthpiece.
HOW LONG CAN THE AEROBIKA® OPEP DEVICE BE USED?
The recommended replacement period for the device is 12 months. If prescribed during a hospital stay, the device can be taken home by the patient for continued use. 30-day post-discharge data has shown this can reduce readmissions for COPD exacerbations and post-operative patients by 28% and 39% respectively.
If you have a question that was not answered here, please contact us.
Clinical Evidence
AEROBIKA® OPEP DEVICE CLINICAL EVIDENCE SUMMARY
A quick view of the most recent peer-reviewed evidence supporting the chambers. Learn more.
AIRWAY CLEARANCE IN THE COVID-19 TREATMENT PATHWAY
An evidence assessment for the integration of the AEROBIKA® OPEP device into the care pathway for COVID-19 patients with airway clearance needs. Watch the video.
USE OF THE AEROBIKA® OPEP DEVICE RESULTED IN DECREASED READMISSIONS VERSUS STANDARD OF CARE
28% decrease in readmissions for COPD exacerbations. Learn more.
39% decrease in all-cause rehospitalizations and lower costs for post-operative recovery. Learn more.
References:
1Svenningsen S. et al. COPD 2016;13(1):66 – 74.
2V Wolkove N, et al. CHEST 2002;121(3):702-7.